The synthesis of the cell wall glycopeptide in Staphylococcus aureus and Micrococcus lysodeikticus from its precursors, UDP-acetylglucosamine (UDP-GlcNAc) and UDP-acetylmuramyl L-ala D-glu L-lys D-ala D-ala (UDP-M\IurNAc-pentapeptide), has been under investigation in several laboratories. -4 The product of this reaction is a linear polymer consisting of alternating GlcNAc-and I\JurNAc-pentapeptide residues. A unique feature of this reaction mechanism is the fact that UM\P and Pi are formed from one of the substrates while UDP is formed from the other.2 I This finding led to the observation that M\IurNAc(-pentapeptide)-P-lipid and GlcNAc-M\IurNAc(-pentapeptide)-P-lipid are intermediates in the reaction.3 This sequence is presumably a means by which the intracellular nucleotides are transported through the membrane for the synthesis of an extracellular product, the cell wall. It also ensures the alternation of the sugars in the glycopeptide product.
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The biosynthesis of the cell wall of S. aureus also requires the formation of polyglycine cross bridges which link glycopeptide chains ill a two-or three-dimensional network, attached at one end to the C-amino groups of lysine and at the other to Dalanine, the carboxyl terminus of the cell wall tetrapeptide.1-7 An important clue to the mechanism of formation of these bridges was the observation that an ATP and uridine nucleotide-requiring system which incorporated glycine into an acidprecipitable product was RNase-sensitive. 1 The product was incompletely characterized, however, and appeared to be lysozyme-insensitive.
With enzyme particles prepared after disintegration of cells of S. aureus with alumina and by incubation at low temperature, an extremely efficient synthesis of glycopeptide is obtained.1 Under these conditions polyglycine chains can also be added to the c-amino groups of lysine in the glycopeptide. In the present paper the mechanism of this reaction will be described. Glycine is activated as glycylsRNA which then transfers glycine to the recently described lipid intermediates in cell wall synthesis.3 The polyglycine-containing lipid intermediates are then used for cell wall synthesis.
Materials and Methods.-Substrates and enzymes from S. aureus strain H were prepared and assays were carried out as described previously3 with changes described in figures or tables. C'4-glycine (80 mc/mmole) and H3-glycine (200 mc/mmole) were obtained from the New England Nuclear Corporation. Products were characterized using the specificity of enzymes which catalyze the hydrolysis of cell walls.2, 3, 6, 7 Free amino groups in products were measured using dinitrofluorobenzene (DNFB). C'4-glycine, dinitrophenyl (DNP)-C14-glycine, C'4-L-lysine, and e-DNP-C14-L-lysine, formed after acid hydrolysis, were readily separated by thin layer chromatography. Similarly, C-terminal C14-glycine was measured after hydrazinolysis. From these data, N-terminal, internal, and C-terminal amino acids could be calculated. Details will be presented in a full publication.
Results.-Utilization of glycine for glycopeptide synthesis: The incorporation of glycine with S. aureus particles was dependent on particles, ATP, supernatant, and both of the uridine nucleotides required for glycopeptide synthesis. It was insensitive to chloramphenicol, puromycin, the glycyl analog of puromycin, and was totally inhibited by RNase (Table 1) . These results largely confirm the results of Chatterjee and Park,' except that, contrary to their report, no requirement for or stimulation by ribosomes has been observed.
Role of sRNA and activating enzyme: These data suggested that glycine might be activated as glycyl-sRNA. sRNA prepared from S. aureus by phenol extraction greatly stimulated the incorporation ( Table 2 ).8 The supernatant also contained a glycine-activating enzyme which was purified 15-fold.9 This purified enzyme, together with sRNA, substituted for the requirement for supernatant ( Table 2 ). This enzyme preparation catalyzed formation of glycine hydroxamate and a glycinedependent ATP-PP exchange. The mechanism of glycine activation was, therefore, the same as that reported for glycine-activating enzyme in rat liver.'0 sRNA from E. coli and its homologous glycine-activating enzyme substituted for S. aureus sRNA and activating enzyme. The conditions are essentially the same as in Table 1 except that 38 pg (as protein) of twicewashed membrane particle enzyme and, where indicated, either 1.3 pg of supernatant fraction or 0.8 pg of glycine-activating enzyme (specific activity: 27 ispzmoles glycyl-sRNA per pg per 10 min) or 50 pg of staphylococcal sRNA were used. In these experiments the amount of activating enzyme was limiting so that the ratio of glycine to MurNAc-pentapeptide incorporated was relatively low.
Glycine is attached to a terminal adenosine group in the sRNA from S. aureus. C14-glycyl-adenosine, liberated by pancreatic RNase digestion of C14-glycyl-sRNA, was purified by the method of Wolfenden, Rammler, and Lipmann."1 On paper chromatography (isobutyric acid: 1 N ammonia, 5:3, Radenosine = 1.0; butanol: formic acid :water, 77:10:13, Radenosine = 0.7) and paper electrophoresis at pH 3.2, it had the same mobilities as glycyl-adenosine prepared from E. coli glycyl-sRNA. After treatment with dilute alkali, an ultraviolet-absorbing material with the mobility of adenosine was obtained. The ultraviolet absorption spectrum of this purified material was identical to that of adenosine.
The glycyl-sRNA was purified by chromatography on DEAE-Sephadex A-50 buffered with 7 M urea, 0.03 M ammonium acetate with a NaCL gradient from 0.52 M to 0.75 M (final pH 4.5).12 Two major peaks of glycyl-sRNA were found (Fig. 1 ). Glycyl-sRNA from peak A substituted for glycine, sRNA, and ATP in glycine incorporation; a maximum of 50 per cent of added glycyl-sRNA was utilized (Fig. 2) . Glycine from this glycyl-sRNA appeared first in the lipid fraction previously described,3 i.e., the material with Rf = 0.9 in isobutyric acid: 1 N NH40H (5:3). After a lag, radioactivity appeared in glycopeptide. These same kinetics have previously been reported for the formation of glycopeptide from UDP-GlcNAc and UDP-MurNAc-pentapeptide, the lag being due to the formation of lipid intermediates.3 Glycyl-sRNA from peak B was inactive ( Fig. 2) . Both of the glycyl-sRNA's were active in protein synthesis with an E. coli ribosomal system.
Transfer of glycine to a lipid intermediate: Four prominent possibilities existed for the acceptor of glycine, viz., UDP-acetylmuramyl-pentapeptide, MurNAc(-pentapeptide)-P-lipid, GlcNAc-MurNAc(-pentapeptide)-P-lipid, and the incomplete glycopeptide itself. The lipid intermediates from S. aureus3 were found to incorporate glycine rapidly, and the glycine-containing product could be observed at the same position on chromatography in isobutyric acid: NH40H (5:3), Rf = 0.9, as the lipids without glycine.
When UDP-GlcNAc was omitted, under which condition MurNAc(-pentapeptide)-P-lipid accumulated, some glycine was incorporated into the lipid fraction. After formation of this lipid intermediate containing glycine linked to MurNAc (-pentapeptide)-P-lipid (Fig. 3) , further glycine addition was prevented by addition of RNase. UDP-GlcNAc was then added and the sample was again incubated. glycopeptide was formed (Fig. 3) . It is clear that GlcNAc can be added to M\lurNAc (-pentapeptide-polyglycine)-P-lipid and that the product can be used for glycopeutide synthesis.
Similarly, GlcNac-1\IurNAc(-pentapeptide)-P-lipid was accumulated in the particles by incubation with both nucleotide substrates. When the glycine incorporation system (glycine, ATP, sRNA, and activating enzyme) was added to these particles, the lipid intermediate was rapidly and extensively labeled by glycine (Fig. 4) . Both the extent and the velocity of labeling were much greater with G1cNAc-MurNAc(-pentapeptide)-P-lipid as the glycine acceptor thaii with MAurNAc(-pentapeptide)-P-lipid (compare Figs. 3 and 4) . After for continued activity of the system in the absence of RNase.
glycine incorporation system.'3 Glycopeptide was allowed to form in the absence of the glycine-incorporating system. Residual substrates were washed out of the particles, and then the glycine-incorporating system was added. Subsequent labeling of the preformed glycopeptide under these conditions was very low, and labeling which did occur was at least partially accounted for by the lipid intermediates which these particles contained. It has not been established whether glycine polymerization occurs on the sRNA or on the lipid. However, polymerization by sequential transfer of glycine to the lipid is suggested by the failure of sensitive methods (C'4-glycine of high specific activity and thin layer chromatography of DNP-amino acids and peptides) to reveal even traces of di-, tri-, tetra-, or penta-glycine in glycyl-sRNA during the reaction.
Effects of inhibitors on glycine addition: Among a variety of substances tested, octanol (3 mg/ml), deoxycholate (1.7 mg/ml), vancomycin (50 ,ug/ml), and ristocetin (50 ,g/ml) have been found to uncouple glycopeptide synthesis. At the low concentrations indicated, all of these substances inhibited utilization of the lipid intermediates containing glycine for glycopeptide synthesis but did not inhibit formation of these glycine-containing lipid intermediates. Several other antibiotics which inhibit cell wall synthesis, penicillin, bacitracin, and novobiocin, had no effect on either the formation or the utilization of the lipid intermediates.
Location of the glycine residues in lipid intermediates and glycopeptide: An average of 1.9 glycine residues was transferred to the e-amino groups of lysine in the lipid intermediates. Some of the lysine residues were not substituted, however, so that the number of glycines transferred per substituted lysine was about 5.14 The N-terminal end of the glycine chain in the lipid intermediate reacted poorly with DNFB. Only one N-terminal glycine was found per 10-20 residues (Table 3) . At the present time we are uncertain whether this represents a technical problem or whether the amino end of the glycine chain is substituted in some unknown manner. In the presence of octanol, virtually all of the 6-amino groups of the lysine residues in the lipid intermediates became substituted with an average of 4.9 glycine residues/ lysine.
The glycopeptide product contained 2.9 glycine residues/lysine. Again some of the e-amino groups of the lysine residues were unsubstituted, so that the actual size of the glycine chains was [4] [5] [6] in various experiments. Similarly, the amount of DNP-glycine found was 1 per 4-6 total glycines ( Table 3 ). The reaction of the N-terminal end of the glycine chains with DNFB indicates that these chains are open and that they remain to be closed to form bridges in some subsequent reaction in cell wall synthesis. Neither the lipid intermediates nor the glycopeptide product contained any C-terminal glycine.
A bacteriolytic enzyme from Cytophaga hydrolyzes glycine bridges in the cell wall with the formation of both tri-and tetraglycine. 5' 16 Both the C14-lipid intermediates and the C-14-glycopeptide product were treated with this enzyme and in both cases C14-triglycine and C14-tetraglycine were formed.
GlcNAc-MurNAc(-pentapeptide-pentaglycine)-P-lipid was insensitive to lysozyme but disaccharide-decapeptide was recovered from it by mild acid hydrolysis. By contrast, the glycopeptide product was unaffected by mild acid but lysozyme hydrolyzed it to several products including disaccharide-decapeptide and tetrasaccharide-bis(decapeptide). Characterization of these materials will be reported in a full paper.
Discussion. Glycyl-sRNA is an intermediate in the process and this is so far the only example of the participation of sRNA in a process other than protein synthesis. The significance of the phenomenon is not completely clear and many of its features still remain to be established. There is presently no evidence for the participation of ribosomes or of a coding mechanism. However, without extensive purification of the components of the system, it is difficult to exclude unequivocally participation of ribosomes bound to the heavy particles (presumed to be derived from cell membrane), even though these particles were prepared in the absence of Mg++. Further purification will also be required to establish whether the glycine-activating enzyme and sRNA involved in cell wall synthesis function uniquely in this system or whether they may also participate in protein synthesis.
Finally, the system reported here may be compared to that employed by Chatterjee and Park.' The major product of the RNase-sensitive glycine incorporation which they observed was insensitive to lysozyme, and other of its features suggest that they in fact were measuring the lipid intermediates described here. These intermediates are precipitable by acid, as is the glycopeptide. iIoreover, although it can be difficult to compare experiments of this kind carried out in different laboratories, particles, prepared after disintegration with glass beads in the MAIickle apparatus and incubated as they described, in our hands catalyze formation of the lipid intermediates but are relatively inefficient in catalyzing glycopeptide synthesis. Summary. In S. aureus glycine is activated for incorporation into cell wall gly-copeptide as glycyl-sRNA. Both the glycine-activating enzyme and the glycylsRNA involved in this reaction have been partially purified. Only one of the two glycyl-sRNA's found in S. aureus was active in cell wall synthesis. This glycylsRNA transferred about five glycine residues, apparently sequentially, to a free e-amino group of lysine in the previously described intermediate, GlcNAc-MurNAc-(-pentapeptide)-P-lipid. The GlcNAc-MurNAc(-pentapeptide-pentaglycine)-Plipid transferred disaccharide-decapeptide to a cell wall acceptor. The glycine chains in this product were open and their closure is required as a further step in cell wall assembly. MurNAc(-pentapeptide)-P-lipid appeared to be a less adequate acceptor of glycine in the in vitro system. The attachment of these glycine residues to lipid intermediates, which are found in the cell membrane, serves as a means by which intracellular precursors are utilized for the synthesis of the cell wall, an essentially extracellular product, and thus these compounds appear to be transport intermediates.
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